The North America Needles Market was valued at USD 1,746 Million in 2025 and is projected to reach USD 3,105 Million by 2035, expanding at a CAGR of 5.6% from 2024 to 2035. The market encompasses a broad spectrum of medical and industrial needles, driven by advancements in healthcare infrastructure and rising chronic disease prevalence.
The economic impact of tariffs on "North America Needles Market".
Market Growth Drivers
Rising prevalence of chronic diseases such as diabetes and cancer has significantly increased the demand for injectable therapies and diagnostics, fueling rapid growth in the need for needles across hospitals and clinics. For instance, Becton, Dickinson and Company (BD) reported increasing sales of their pen needles and safety-engineered devices due to higher insulin administration and vaccination rates throughout 2023.
Continuous technological advancements in needle design, such as ultra-thin and safety-engineered variants, are making procedures safer and less painful, thereby encouraging both patient and provider adoption. Companies like Terumo Corporation have introduced new needle technologies that reduce patient discomfort and improve user safety, aligning with the region’s focus on minimally invasive procedures.
Market Trends
Integration of smart technologies in needle systems is emerging as a key trend, with devices now offering digital dose tracking and connectivity for remote patient monitoring. B. Braun Melsungen AG, for example, has recently piloted smart syringes and needle solutions for outpatient care, enabling enhanced accuracy and compliance.
Sustainability and recyclability are becoming important, as major players like Smiths Medical are moving toward environmentally friendly production and recycling programs for medical waste. This is evident from the launch of their eco-friendly needle disposal systems in Q1 2024, addressing rising regulatory and societal demands for greener healthcare solutions.
Market Opportunity
The growing adoption of at-home care and self-administration of drugs presents a significant opportunity for companies like BD and Novo Nordisk to develop user-friendly, pre-filled needle systems that cater to patients managing chronic conditions outside of traditional clinical settings.
Expansion into under-served rural and remote healthcare settings is a promising avenue, with organizations such as Medtronic targeting distribution partnerships to supply affordable, high-quality needles to healthcare providers in North American rural communities.
North America Needles Market Revenue (USD Million), 2020-2035
The chart shows steady revenue growth in the North America Needles Market from 2020 to 2035. In 2020, the market stood at USD 1,200 Million and experienced incremental but consistent increases, attributed to both rising chronic illnesses and technological innovations. The market reached USD 1,746 Million in 2025, with projections indicating accelerated expansion to USD 3,105 Million by 2035. This upward trajectory reflects the ongoing increase in minimally invasive procedures, higher demand for injections and insulin therapies, as well as new product launches catering to improved patient and provider experiences.
North America Needles Market by Regional Share (%) in 2025
The 2025 market share breakdown by region shows the United States clearly dominating the North America Needles Market, holding 72% of total market share due to its robust healthcare system and high adoption of advanced medical devices. Canada accounts for 18%, supported by increasing government healthcare spending and expanding hospital infrastructure. Mexico follows with 6%, as access to healthcare and chronic disease treatments rise. The rest of North America, including various territories, represents 4%, highlighting gradual market penetration. The data demonstrates a strong skew towards developed healthcare systems within the region, with ongoing opportunities for further market penetration in less saturated areas.
Recent Developments in the North America Needles Market
In March 2024, Becton, Dickinson and Company (BD) announced the launch of a new range of ultra-fine pen needles with enhanced ergonomic design for diabetes patients. The new needles reduce injection pain and are compatible with most pen devices, addressing increasing patient comfort and technical requirements in insulin administration.
In April 2024, Smiths Medical introduced its first recyclable safety needle disposal box for hospitals in the United States and Canada. This innovative solution aims to address environmental concerns by enabling proper disposal and recycling of used medical needles, aligning with broader ESG (Environmental, Social, and Governance) objectives in healthcare.
In May 2024, Terumo Corporation expanded its North American market presence by opening a new manufacturing facility in Texas, dedicated to producing high-volume safety needles and syringes. This strategic move aims to meet growing demand while minimizing supply chain disruptions, ensuring timely access to essential medical products throughout the region.
Press Releases